New strategies in colon cancer adjuvant therapy

R. Labianca, S. Mosconi, M. C. Garassino

Research output: Contribution to journalArticlepeer-review


Adjuvant therapy in colorectal cancer has always been a controversy during years. Despite the fact that benefit of adjuvant therapy in stage III is clear, a more controversial question concerns efficacy in stage II. The introduction of new drugs in addition to standard regimens has some benefit, but also adds toxicity. Ongoing studies with novel targeted therapies will show their results in the next years. Other open questions include duration of therapy and whether there is a real possibility of selecting patients for treatment on the basis of prognostic factors.

Original languageEnglish
JournalAnnals of Oncology
Issue numberSUPPL. 7
Publication statusPublished - Jun 2006


  • Adjuvant therapy
  • Colon cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'New strategies in colon cancer adjuvant therapy'. Together they form a unique fingerprint.

Cite this